Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders
Clinical trial NCT00002153 · COMPLETED
Trial details
- NCT number
- NCT00002153
- Sponsor
- DEKK-TEC, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.